Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS).

G R Verelst, Silvia; M Blommestein, Hedwig; De Groot, Saskia; Gonzalez-McQuire, Sebastian; DeCosta, Lucy; B de Raad, Johan; A Uyl-de Groot, Carin; Sonneveld, Pieter

doi:10.1097/hs9.0000000000000045

Public

Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS).

Published in HemaSphere • Aug 1, 2018

NobleIDark:/48914/w1/20260526/CF93820FRecord on NobleID

Authors:

Silvia G R Verelst

,

Hedwig M Blommestein

,

Saskia De Groot

Abstract

Registry data are important for monitoring the impact of new therapies on treatment algorithms and outcomes, and for guiding clinical decision making in multiple myeloma (MM). This observational study analyzed real-world data from patients in the Population-based HAematological Registry for Observat...

Discussions